| 000 | 01517 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513160330.0 | ||
| 264 | 0 | _c19990322 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHum, M | |
| 245 | 0 | 0 |
_aHigh-dose trimetrexate and minimal-dose leucovorin: a case for selective protection? _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cDec 1998 |
||
| 300 |
_a2981-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntidotes |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 |
_aMucous Membrane _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTrimetrexate _xadverse effects |
| 700 | 1 | _aHolcenberg, J S | |
| 700 | 1 | _aTkaczewski, I | |
| 700 | 1 | _aWeaver, J W | |
| 700 | 1 | _aWilson, J | |
| 700 | 1 | _aKamen, B A | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 4 _gno. 12 _gp. 2981-4 |
|
| 999 |
_c9828672 _d9828672 |
||